Management of scleroderma gastrointestinal disease: Lights and shadows

Jenice X. Cheah, Dinesh Khanna, Zsuzsanna H. McMahan

Research output: Contribution to journalEditorialpeer-review


Gastrointestinal symptoms affect the great majority of patients with systemic sclerosis. Management of these complications is often challenging as any region of the gastrointestinal tract may be involved, and significant heterogeneity exists in clinical presentation, kinetics, and outcomes. Here, we highlight new findings relevant to the management of systemic sclerosis-related gastrointestinal disease (lights) and consider areas that we have yet to elucidate (shadows).

Original languageEnglish (US)
JournalJournal of Scleroderma and Related Disorders
StateAccepted/In press - 2022


  • GI complications
  • SSc-related gastrointestinal disease
  • Systemic sclerosis
  • dysmotility
  • gastrointestinal
  • management
  • scleroderma complications

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology


Dive into the research topics of 'Management of scleroderma gastrointestinal disease: Lights and shadows'. Together they form a unique fingerprint.

Cite this